Synonyms: compound 1a [WO2015014972]
Compound class:
Synthetic organic
Comment: JS6 is a small molecule that was designed to investigate the antimetastatic potential of inhibiting the BCL3 transcription coactivator [1]. Overexpressed BCL3 is an established oncogenic driver in some leukemias and solid tumours. J6S disrupts the interaction of BCL3 with its cognate protein partner NF-κB1 (p50).
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
JS6 inhibits the BCL3-NF-κB1 (p50) interaction with an IC50 of 285 nM [2]. |
Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|